Biolife is committed to upholding the integrity of all its publications. It is necessary
therefore to agree on the standards of ethical behavior expected from all parties involved
in the publishing process; these include the author, the editor, the peer reviewer and the
publisher. Biolife follows the COPE Best Practice Guidelines on publishing ethics. Full
details of these guidelines can be found on the COPE website.
Biolife does not tolerate plagiarism, or the publication of material that is libelous, illegal or
which infringes the copyright or other rights of any third party. In addition, the manipulation
of scientific data, tables, figures or any text for the purpose of knowingly providing incorrect
information in order to manipulate the process of peer review is strictly prohibited.
Authors publishing a paper with Biolife should certify that (i) all those mentioned in the list
of authors have contributed significantly to the paper, (ii) no person who has made a
significant contribution has been omitted from the list of authors or acknowledged persons,
(iii) all sources of external funding have been revealed in the acknowledgments section,
(iv) the paper has not been and will not be submitted to any other publication until either
the review process has been completed or the paper has been withdrawn, (v) the
submitting author assumes responsibility, within the limits of his or her professional
competence, for the accuracy of the paper, and (vi) the authors have read and agree to
the Biolife copyright agreement.
The editor or peer reviewer of any Biolife publication shall evaluate manuscripts on their
intellectual content, irrespective of the race, gender, sexual orientation, religious belief,
ethnic origin, citizenship, or political philosophy of the authors. The editor and any editorial
staff shall not disclose any confidential information concerning a submitted manuscript to
anyone other than the corresponding author, reviewers, potential reviewers, other editorial
advisers, or publisher, as appropriate. The content of any unpublished materials disclosed
in a submitted manuscript is not to be used, either in whole or in part, in an editor’s own
research without the express written consent of the submitting author.
The publisher, Biolife, affirms that any misconduct, in the form of fabrication, falsification or
plagiarism, jeopardizes the success of the entire scientific endeavor. Any questions raised
with regard to possible misconduct or plagiarism will initially be evaluated by the editor(s)
of the publication, in consultation with the manuscript’s peer reviewer(s) if appropriate. If
deemed appropriate, the matter will be taken up with the institution where the scientific
work in question was performed. In principle, matters will be reviewed in accordance with
the institutional procedures for handling allegations of misconduct. At all stages, every
effort should be made to ensure that the process is fair and just, both for those who have
been accused of misconduct and for those who have raised the issue of scientific
misconduct. In the event that a published article must be retracted or corrected, a
statement of retraction or correction, usually in the form of an erratum, will be published.
Articles may be removed from the publication if deemed appropriate.
Biolife expects authors to abide by the general ethics polices outlined by The Council of
Scientific Editors and COPE. Please use the links below as references.
COUNCIL OF SCIENTIFIC EDITORS
CSE’s White Paper on Promoting Integrity in Scientific Journal Publications:
Download a PDF of the entire White Paper
Responsible research publication: International standards for authors: